Amberjack funds sell 6,612,500 Innovex (INVX) shares in secondary deal

Rhea-AI Filing Summary

Amberjack-affiliated investment funds sold 6,612,500 shares of Innovex International common stock in an underwritten secondary offering. The shares were sold at a public offering price of $25.75 per share, and the selling funds received $24.59125 per share after underwriting discounts.

The transactions were reported as indirect sales by entities including Amberjack Capital Fund II, Innovex Co-Invest Fund II, Innovex Co-Invest Fund, Intervale Capital Fund II, Intervale Capital Fund II-A, and Intervale Capital Fund III. Footnotes state that Amberjack Management and related general partners may be deemed beneficial owners, while managing partner Jason Turowsky disclaims beneficial ownership beyond his economic interest.

Insights

Institutional ownership specialist

Large Amberjack-led funds reduced their Innovex stake via a secondary sale.

Several Amberjack-affiliated funds collectively sold 6,612,500 shares of Innovex International common stock in an underwritten secondary offering. The public paid $25.75 per share, while the funds received $24.59125 per share after underwriting discounts.

The sales are attributed to multiple limited partnerships, with control and voting described through a chain of general partners and Amberjack Management. A key footnote states that Jason Turowsky, managing partner of Amberjack Management, disclaims beneficial ownership beyond his pecuniary interest, highlighting that these are fund-level portfolio moves rather than clearly personal share sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amberjack Capital Partners, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		S		4,902,244	D	$24.5913(1)(7)(8)(9)(10)	16,871,374	I	By Amberjack Capital Fund II, L.P.
Common Stock	02/27/2026		S		1,144,635	D	$24.5913(2)(7)(8)(9)(10)	3,939,330	I	By Innovex Co-Invest Fund II, L.P.
Common Stock	02/27/2026		S		271,279	D	$24.5913(3)(7)(8)(9)(10)	933,624	I	By Innovex Co-Invest Fund, L.P.
Common Stock	02/27/2026		S		234,009	D	$24.5913(4)(7)(8)(9)(10)	805,355	I	By Intervale Capital Fund II, L.P.
Common Stock	02/27/2026		S		116	D	$24.5913(5)(7)(8)(9)(10)	399	I	By Intervale Capital Fund II-A, L.P.
Common Stock	02/27/2026		S		60,217	D	$24.5913(6)(7)(8)(9)(10)	207,240	I	By Intervale Capital Fund III, L.P.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Amberjack Capital Partners, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Amberjack Capital Associates II, LLC

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Amberjack Capital Fund II, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Amberjack Capital GP II, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Innovex Co-Invest Associates, LLC

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Innovex Co-Invest Fund II GP, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Innovex Co-Invest Fund II, L.P.

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Turowsky Jason

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Amberjack Management, LLC

(Last) (First) (Middle)

4400 POST OAK PARKWAY

SUITE 2760

(Street)

HOUSTON TX 77027

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.

8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".

9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.

10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.

Remarks:

This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Innovex Co-Invest Fund, L.P.

	AMBERJACK CAPITAL PARTNERS, L.P., By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Managing Partner	02/27/2026
	AMBERJACK CAPITAL FUND II, L.P., By: Amberjack Capital GP II, L.P., its general partner, By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	AMBERJACK CAPITAL GP II, L.P., By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	AMBERJACK CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	AMBERJACK MANAGEMENT, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	JASON TUROWSKY, /s/ Jason Turowsky	02/27/2026
	INNOVEX CO-INVEST FUND II, L.P., By: Innovex Co-Invest Fund II GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	INNOVEX CO-INVEST FUND II GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	INNOVEX CO-INVEST ASSOCIATES, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Innovex International (INVX) shares did Amberjack funds sell?

The Amberjack-affiliated funds sold 6,612,500 shares of Innovex International common stock. These sales were spread across several related limited partnerships and were executed as part of an underwritten secondary offering, rather than through ordinary open-market trading.

What price did Innovex International (INVX) shares sell for in the Amberjack secondary?

The shares were sold to the public at $25.75 per share. The selling funds received $24.59125 per share, reflecting the public offering price less underwriting discounts, as is typical in an underwritten secondary equity offering.

Which entities actually sold Innovex International (INVX) shares in this Form 4 filing?

The sellers were funds including Amberjack Capital Fund II, Innovex Co-Invest Fund II, Innovex Co-Invest Fund, Intervale Capital Fund II, Intervale Capital Fund II-A, and Intervale Capital Fund III, each holding Innovex common stock directly.

Was Jason Turowsky personally selling Innovex International (INVX) shares?

The filing notes Jason Turowsky as managing partner of Amberjack Management but states he disclaims beneficial ownership of securities beyond his pecuniary interest. The transactions are attributed to the affiliated funds, not clearly to personal trading.

What kind of transaction was reported for Innovex International (INVX) in this Form 4?

The Form 4 reports open-market style sales executed through an underwritten secondary offering of Innovex common stock. All six transactions are coded as sales of non-derivative common shares by the Amberjack-affiliated funds.

How is control over the sold Innovex International (INVX) shares structured among Amberjack entities?

Footnotes explain that various general partners and Amberjack Management control voting and dispositive power for the Amberjack and Innovex Co-Invest funds. Through these relationships, they may be deemed beneficial owners of the reported Innovex shares.